.svg){kind=small}
Slate Milk
|
June 24, 2026
Slate Milk's Triple-Digit Growth with Rolling Funding
As demand for its doctor-formulated menopause-focused products grew, MenoLabs partnered with Clearco to scale their product expansion and bring new solutions to women navigating an often-overlooked stage of life.
“We’ve seen a ton of growth this year despite COVID because middle aged women’s health issues have been ignored for years. Quick access to capital allows us to focus on creating these solutions and help women across the U.S. live better lives”
– Vanessa Ford,
Co-Founder, MenoLabs
The Challenge
Expanding Product Lines Without Eliminating Cash Flow
As demand increased for MenoLabs’ products, the team faced a daunting challenge: expanding their product offering quickly enough to meet customer needs. With more than 6,000 women entering menopause every day, the opportunity—and responsibility—to provide better solutions was growing rapidly.
The Solution
Cash Advance to Fund Menopause Product Innovation
MenoLabs partnered with Clearco to bring more menopause solutions to market. With this funding, the company could invest confidently in innovation, helping them scale beyond a single product and build a more comprehensive women's health platform.
The Results
Three New Products Launched, Including a Tracking App
With access to growth capital, MenoLabs expanded its product portfolio and launched multiple new solutions, including a sleep aid, a fiber supplement, and an innovative menopause symptom tracking app.
These additions enabled MenoLabs to serve customers across more aspects of their health journey, while strengthening its position as a trusted resource for menopause education and support.
